1) NEW FINANCING to last us 18 months,
2) DOMINION CAPITAL has confidence we will succeed,
3) LymPro IS ON TARGET according to a statement by Gerald 2 weeks ago,
4) DR. BIER, a Diagnostic Expert, was hired to commercialize LymPro,
5) $500,000 GRANT given to Helsinki Scientist studying MANF/Diabetes,
6) RODMAN CONFERENCE PRESENTATION by Gerald suggests AMBS is recognized by the Big Boys,
7) BD VALIDATION RESULTS to be made public within next couple of weeks, or even days,
8) MORE ORPHAN DRUG ANNOUNCEMENTS on MANF indications coming this month.
These are some of the reasons why the stock price of AMBS has been rising this past month. These developments are elevating us to a more appropriate valuation level in the .25 to 50 cent range within the next few weeks!! If a partnership with a major Pharma is announced on one of MANF's several indications, then the calculus of our valuation changes dramatically. I don't want to speculate on that, but that is a definite possibility at some point in our future. These reasons give an investor the basis of confidence to load up on this stock now, having good reason to believe the stock is headed much, much higher.